Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 286

The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.

Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond

Open access
Yin, Rui, Dai, Tianhong, Avci, Pinar, Jorge, Ana Elisa Serafim, de Melo, Wanessa CMA, Vecchio, Daniela, Huang, Ying-Ying, Gupta, Asheesh, Hamblin, Michael R·2013·Current Opinion in Pharmacology

Abstract

Owing to the worldwide increase in antibiotic resistance, researchers are investigating alternative anti-infective strategies to which it is supposed microorganisms will be unable to develop resistance. Prominent among these strategies, is a group of approaches which rely on light to deliver the killing blow. As is well known, ultraviolet light, particularly UVC (200–280nm), is germicidal, but it has not been much developed as an anti-infective approach until recently, when it was realized that the possible adverse effects to host tissue were relatively minor compared to its high activity in killing pathogens. Photodynamic therapy is the combination of non-toxic photosensitizing dyes with harmless visible light that together produce abundant destructive reactive oxygen species (ROS). Certain cationic dyes or photosensitizers have good specificity for binding to microbial cells while sparing host mammalian cells and can be used for treating many localized infections, both superficial and even deep-seated by using fiber optic delivered light. Many microbial cells are highly sensitive to killing by blue light (400–470 nm) due to accumulation of naturally occurring photosensitizers such as porphyrins and flavins. Near infrared light has also been shown to have antimicrobial effects against certain species. Clinical applications of these technologies include skin, dental, wound, stomach, nasal, toenail and other infections which are amenable to effective light delivery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.coph.2013.08.009

Cites

191 of 191 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 191 references

Research works printed but not linked: 94

  1. Bell, 2003, Antibiotic resistance: is the end of an era near?, Neonatal Netw, 22, 47, 10.1891/0730-0832.22.6.47 · doi:10.1891/0730-0832.22.6.47
  2. Su, 2011, Photodynamic antimicrobial activity of hypocrellin A, J Photochem Photobiol B, 103, 29, 10.1016/j.jphotobiol.2011.01.008 · doi:10.1016/j.jphotobiol.2011.01.008
  3. Bak, 2009, Dose requirements for UVC disinfection of catheter biofilms, Biofouling, 25, 289, 10.1080/08927010802716623 · doi:10.1080/08927010802716623
  4. Dai, 2008, Ultraviolet C inactivation of dermatophytes: implications for treatment of onychomycosis, Br J Dermatol, 158, 1239, 10.1111/j.1365-2133.2008.08549.x · doi:10.1111/j.1365-2133.2008.08549.x
  5. Sullivan, 2000, A comparative study of the effects of UVC irradiation on select procaryotic and eucaryotic wound pathogens, Ostomy Wound Manage, 46, 28
  6. Dai, 2012, Ultraviolet C light for Acinetobacter baumannii wound infections in mice: potential use for battlefield wound decontamination?, J Trauma Acute Care Surg, 73, 661, 10.1097/TA.0b013e31825c149c · doi:10.1097/ta.0b013e31825c149c
  7. Sosnin, 2004, The effects of UV irradiation and gas plasma treatment on living mammalian cells and bacteria: a comparative approach, IEEE Trans Plasma Sci, 32, 1544, 10.1109/TPS.2004.833401 · doi:10.1109/tps.2004.833401
  8. Dai, 2011, Ultraviolet-C irradiation for prevention of central venous catheter-related infections: an in vitro study, Photochem Photobiol, 87, 250, 10.1111/j.1751-1097.2010.00819.x · doi:10.1111/j.1751-1097.2010.00819.x
  9. Freytes, 1965, Ultraviolet light in the treatment of indolent ulcers, South Med J, 58, 223, 10.1097/00007611-196502000-00017 · doi:10.1097/00007611-196502000-00017
  10. Thai, 2002, Ultraviolet light C in the treatment of chronic wounds with MRSA: a case study, Ostomy Wound Manage, 48, 52
  11. Thai, 2005, Effect of ultraviolet light C on bacterial colonization in chronic wounds, Ostomy Wound Manage, 51, 32
  12. Boker, 2007, A single-center, prospective, open-label, pilot study of the safety, local tolerability, and efficacy of ultraviolet-C (UVC) phototherapy for the treatment of great toenail onychomycosis, J Am Acad Dermatol, 58, AB82
  13. Shimomura, 1995, The effect of ultraviolet rays on the prevention of exit-site infections, Adv Perit Dial, 11, 152
  14. Tome, 2004, Synthesis and antibacterial activity of new poly-S-lysine-porphyrin conjugates, J Med Chem, 47, 6649, 10.1021/jm040802v · doi:10.1021/jm040802v
  15. Schastak, 2010, Efficient photodynamic therapy against Gram-positive and Gram-negative bacteria using THPTS, a cationic photosensitizer excited by infrared wavelength, PLoS ONE, 5, e11674, 10.1371/journal.pone.0011674 · doi:10.1371/journal.pone.0011674
  16. Schastak, 2008, Improved photoinactivation of Gram-negative and Gram-positive methicillin-resistant bacterial strains using a new near-infrared absorbing meso-tetrahydroporphyrin: a comparative study with a chlorine e6 photosensitizer photolon, Methods Find Exp Clin Pharmacol, 30, 129, 10.1358/mf.2008.30.2.1165448 · doi:10.1358/mf.2008.30.2.1165448
  17. Wainwright, 1999, Photobactericidal activity of methylene blue derivatives against vancomycin-resistant Enterococcus spp., J Antimicrob Chemother, 44, 823, 10.1093/jac/44.6.823 · doi:10.1093/jac/44.6.823
  18. Xing, 2011, Multifunctional divalent vancomycin: the fluorescent imaging and photodynamic antimicrobial properties for drug resistant bacteria, Chem Commun (Camb), 47, 1601, 10.1039/C0CC04434B · doi:10.1039/c0cc04434b
  19. Tseng, 2009, Toluidine blue O photodynamic inactivation on multidrug-resistant Pseudomonas aeruginosa, Lasers Surg Med, 41, 391, 10.1002/lsm.20765 · doi:10.1002/lsm.20765
  20. Kussovski, 2009, Photodynamic inactivation of Aeromonas hydrophila by cationic phthalocyanines with different hydrophobicity, FEMS Microbiol Lett, 294, 133, 10.1111/j.1574-6968.2009.01555.x · doi:10.1111/j.1574-6968.2009.01555.x
  21. Trannoy, 2006, Differential sensitivities of pathogens in red cell concentrates to Tri-P(4)-photoinactivation, Vox Sanguinis, 91, 111, 10.1111/j.1423-0410.2006.00791.x · doi:10.1111/j.1423-0410.2006.00791.x
  22. O’Riordan, 2007, Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection, Photochem Photobiol Sci, 6, 1117, 10.1039/b707962a · doi:10.1039/b707962a
  23. Wiegell, 2006, Mycobacterium marinum infection cured by photodynamic therapy, Arch Dermatol, 142, 1241, 10.1001/archderm.142.9.1241 · doi:10.1001/archderm.142.9.1241
  24. Shih, 2011, Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis, Invest Ophthalmol Vis Sci, 52, 223, 10.1167/iovs.10-5593 · doi:10.1167/iovs.10-5593
  25. Thota, 2012, Synthesis and characterization of positively charged pentacationic [60]fullerene monoadducts for antimicrobial photodynamic inactivation, Molecules, 17, 5225, 10.3390/molecules17055225 · doi:10.3390/molecules17055225
  26. Yang, 2012, Wheat germ agglutinin modified liposomes for the photodynamic inactivation of bacteria, Photochem Photobiol, 88, 548, 10.1111/j.1751-1097.2011.00983.x · doi:10.1111/j.1751-1097.2011.00983.x
  27. Hamblin, 2003, Optical monitoring and treatment of potentially lethal wound infections in vivo, J Infect Dis, 187, 1717, 10.1086/375244 · doi:10.1086/375244
  28. Berthiaume, 1994, Antibody-targeted photolysis of bacteria in vivo, Biotechnology (N Y), 12, 703, 10.1038/nbt0794-703 · doi:10.1038/nbt0794-703
  29. Hashimoto, 2012, Antimicrobial photodynamic therapy on drug-resistant Pseudomonas aeruginosa-induced infection. An in vivo study, Photochem Photobiol, 88, 590, 10.1111/j.1751-1097.2012.01137.x · doi:10.1111/j.1751-1097.2012.01137.x
  30. Park, 2012, In vitro and in vivo antimicrobial effect of photodynamic therapy using a highly pure chlorin e6 against Staphylococcus aureus Xen29, Biol Pharm Bull, 35, 509, 10.1248/bpb.35.509 · doi:10.1248/bpb.35.509
  31. Goto, 2011, Therapeutic effect of photodynamic therapy using Na-pheophorbide A on osteomyelitis models in rats, Photomed Laser Surg, 29, 183, 10.1089/pho.2010.2803 · doi:10.1089/pho.2010.2803
  32. Shibli, 2003, Lethal photosensitization in microbiological treatment of ligature-induced peri-implantitis: a preliminary study in dogs, J Oral Sci, 45, 17, 10.2334/josnusd.45.17 · doi:10.2334/josnusd.45.17
  33. Bottura, 2011, Nonsurgical periodontal therapy combined with laser and photodynamic therapies for periodontal disease in immunosuppressed rats, Transplant Proc, 43, 2009, 10.1016/j.transproceed.2011.03.083 · doi:10.1016/j.transproceed.2011.03.083
  34. de Almeida, 2008, Treatment of experimental periodontal disease by photodynamic therapy in rats with diabetes, J Periodontol, 79, 2156, 10.1902/jop.2008.080103 · doi:10.1902/jop.2008.080103
  35. de Almeida, 2007, Influence of photodynamic therapy on the development of ligature-induced periodontitis in rats, J Periodontol, 78, 566, 10.1902/jop.2007.060214 · doi:10.1902/jop.2007.060214
  36. Lazarova, 1993, Effect of glutathione on Rose Bengal photosensitized yeast damage, Microbios, 75, 39
  37. Smijs, 2003, Photodynamic inactivation of the dermatophyte Trichophyton rubrum, Photochem Photobiol, 77, 556, 10.1562/0031-8655(2003)077<0556:PIOTDT>2.0.CO;2 · doi:10.1562/0031-8655(2003)077<0556:piotdt>2.0.co;2
  38. Smijs, 2004, Photodynamic treatment of the dermatophyte Trichophyton rubrum and its microconidia with porphyrin photosensitizers, Photochem Photobiol, 80, 197, 10.1562/2004-04-22-RA-146.1 · doi:10.1562/2004-04-22-ra-146.1
  39. Friedberg, 2001, In vitro effects of photodynamic therapy on Aspergillus fumigatus, J Antimicrob Chemother, 48, 105, 10.1093/jac/48.1.105 · doi:10.1093/jac/48.1.105
  40. Lin, 2004, Use of merocyanine 540 for photodynamic inactivation of Staphylococcus aureus planktonic and biofilm cells, Appl Environ Microbiol, 70, 6453, 10.1128/AEM.70.11.6453-6458.2004 · doi:10.1128/aem.70.11.6453-6458.2004
  41. Goulart Rde, 2010, Comparative study of methylene blue and erythrosine dyes employed in photodynamic therapy for inactivation of planktonic and biofilm-cultivated Aggregatibacter actinomycetemcomitans, Photomed Laser Surg, 28, S85, 10.1089/pho.2009.2698 · doi:10.1089/pho.2009.2698
  42. Jori, 2006, Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications, Lasers Surg Med, 38, 468, 10.1002/lsm.20361 · DOI · Paper page
  43. Kassab, 2003, Phthalocyanine-photosensitized inactivation of a pathogenic protozoan, Acanthamoeba palestinensis, Photochem Photobiol Sci, 2, 668, 10.1039/b300293d · doi:10.1039/b300293d
  44. Chen, 2008, In vitro amoebacidal activity of photodynamic therapy on Acanthamoeba, Br J Ophthalmol, 92, 1283, 10.1136/bjo.2007.134288 · doi:10.1136/bjo.2007.134288
  45. Siddiqui, 2012, Photochemotherapeutic strategies against Acanthamoeba keratitis, AMB Express, 2, 47, 10.1186/2191-0855-2-47 · doi:10.1186/2191-0855-2-47
  46. Akilov, 2007, Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation, Photochem Photobiol Sci, 6, 1067, 10.1039/b703521g · doi:10.1039/b703521g
  47. Akilov, 2009, Optimization of topical photodynamic therapy with 3,7-bis(di-n-butylamino)phenothiazin-5-ium bromide for cutaneous leishmaniasis, Lasers Surg Med, 41, 358, 10.1002/lsm.20775 · doi:10.1002/lsm.20775
  48. Hernandez, 2012, In vitro phototoxicity of ultradeformable liposomes containing chloroaluminum phthalocyanine against New World Leishmania species, J Photochem Photobiol B, 117C, 157, 10.1016/j.jphotobiol.2012.09.018 · doi:10.1016/j.jphotobiol.2012.09.018
  49. Taylor, 2011, In vitro and in vivo studies of the utility of dimethyl and diethyl carbaporphyrin ketals in treatment of cutaneous leishmaniasis, Antimicrob Agents Chemother, 55, 4755, 10.1128/AAC.00671-11 · doi:10.1128/aac.00671-11
  50. Lustigman, 1996, Photosensitized inactivation of Plasmodium falciparum in human red cells by phthalocyanines, Transfusion, 36, 543, 10.1046/j.1537-2995.1996.36696269514.x · doi:10.1046/j.1537-2995.1996.36696269514.x
  51. Wagner, 2008, Inactivation of Leishmania donovani infantum and Trypanosoma cruzi in red cell suspensions with thiazole orange, Transfusion, 48, 1363, 10.1111/j.1537-2995.2008.01712.x · doi:10.1111/j.1537-2995.2008.01712.x
  52. Docampo, 1988, Prevention of Chagas’ disease resulting from blood transfusion by treatment of blood: toxicity and mode of action of gentian violet, Biomed Environ Sci, 1, 406
  53. Docampo, 1988, Enhancement of the cytotoxicity of crystal violet against Trypanosoma cruzi in the blood by ascorbate, Mol Biochem Parasitol, 27, 241, 10.1016/0166-6851(88)90043-6 · doi:10.1016/0166-6851(88)90043-6
  54. Gottlieb, 1996, Inactivation of Trypanosoma cruzi trypomastigote forms in blood components with a Psoralen and Ultraviolet A light, Photochem Photobiol, 63, 562, 10.1111/j.1751-1097.1996.tb05656.x · doi:10.1111/j.1751-1097.1996.tb05656.x
  55. Gottlieb, 1995, Inactivation of Trypanosoma cruzi trypomastigote forms in blood components by photodynamic treatment with phthalocyanines, Photochem Photobiol, 62, 869, 10.1111/j.1751-1097.1995.tb09149.x · doi:10.1111/j.1751-1097.1995.tb09149.x
  56. Hirayama, 1999, Photoinactivation of vesicular stomatitis virus with fullerene conjugated with methoxy polyethylene glycol amine, Biol Pharm Bull, 22, 1106, 10.1248/bpb.22.1106 · doi:10.1248/bpb.22.1106
  57. Lin, 2000, Light-independent inactivation of dengue-2 virus by carboxyfullerene C3 isomer, Virology, 275, 258, 10.1006/viro.2000.0490 · doi:10.1006/viro.2000.0490
  58. Shao, 2010, Synthesis and photoactivated insecticidal activity of tetraethynylsilanes, J Photochem Photobiol B, 98, 52, 10.1016/j.jphotobiol.2009.11.003 · doi:10.1016/j.jphotobiol.2009.11.003
  59. Ling, 2000, Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period, JAMA, 284, 210, 10.1001/jama.284.2.210 · doi:10.1001/jama.284.2.210
  60. Al Shaer, 2012, Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009, Transfusion, 52, 2300, 10.1111/j.1537-2995.2012.03740.x · doi:10.1111/j.1537-2995.2012.03740.x
  61. Aznar, 1999, Factor VIII/von Willebrand factor complex in methylene blue-treated fresh plasma, Transfusion, 39, 748, 10.1046/j.1537-2995.1999.39070748.x · doi:10.1046/j.1537-2995.1999.39070748.x
  62. Wainwright, 2002, Pathogen inactivation in blood products, Curr Med Chem, 9, 127, 10.2174/0929867023371355 · doi:10.2174/0929867023371355
  63. Wagner, 2000, The use of dimethylmethylene blue for virus photoinactivation of red cell suspensions, Dev Biol (Basel), 102, 125
  64. Skripchenko, 2000, Inactivation of WBCs in RBC suspensions by photoactive phenothiazine dyes: comparison of dimethylmethylene blue and MB, Transfusion, 40, 968, 10.1046/j.1537-2995.2000.40080968.x · doi:10.1046/j.1537-2995.2000.40080968.x
  65. Hirayama, 2001, Involvement of reactive oxygen species in hemoglobin oxidation and virus inactivation by 1,9-dimethylmethylene blue phototreatment, Biol Pharm Bull, 24, 418, 10.1248/bpb.24.418 · doi:10.1248/bpb.24.418
  66. Schuyler, 2001, Use of riboflavin for photoinactivation of pathogens in blood components, Transfus Apher Sci, 25, 189, 10.1016/S1473-0502(01)00119-7 · doi:10.1016/s1473-0502(01)00119-7
  67. Sobral, 2012, Viral inactivation in hemotherapy: systematic review on inactivators with action on nucleic acids, Rev Bras Hematol Hemoter, 34, 231, 10.5581/1516-8484.20120056 · doi:10.5581/1516-8484.20120056
  68. Antic, 2012, Evaluation of coagulation factors in fresh frozen plasma treated with riboflavin and ultraviolet light, Vojnosanit Pregl, 69, 22, 10.2298/VSP1201022A · doi:10.2298/vsp1201022a
  69. Stanojkovic, 2011, Effects of use of riboflavin and ultraviolet light for pathogen inactivation on quality of platelet concentrates, Vojnosanit Pregl, 68, 489, 10.2298/VSP1106489S · doi:10.2298/vsp1106489s
  70. Jori, 2007, Inactivation of pathogenic microorganisms by photodynamic techniques: mechanistic aspects and perspective applications, Anti-Infect Agents Med Chem, 6, 119, 10.2174/187152107780361652 · doi:10.2174/187152107780361652
  71. Carvalho, 2007, Photoinactivation of bacteria in wastewater by porphyrins: bacterial beta-galactosidase activity and leucine-uptake as methods to monitor the process, J Photochem Photobiol B, 88, 112, 10.1016/j.jphotobiol.2007.04.015 · doi:10.1016/j.jphotobiol.2007.04.015
  72. Alouini, 2001, Destruction of helminth eggs by photosensitized porphyrin, J Environ Monit, 3, 548, 10.1039/b103471p · doi:10.1039/b103471p
  73. Shrestha, 2012, Characterization of a conjugate between Rose Bengal and chitosan for targeted antibiofilm and tissue stabilization effects as a potential treatment of infected dentin, Antimicrob Agents Chemother, 56, 4876, 10.1128/AAC.00810-12 · doi:10.1128/aac.00810-12
  74. Dörtbudak, 2001, Lethal photosensitization for decontamination of implant surfaces in the treatment of peri-implantitis, Clin Oral Implants Res, 12, 104, 10.1034/j.1600-0501.2001.012002104.x · DOI · Paper page
  75. Piraccini, 2008, Photodynamic therapy of onychomycosis caused by Trichophyton rubrum, J Am Acad Dermatol, 59, S75, 10.1016/j.jaad.2008.06.015 · doi:10.1016/j.jaad.2008.06.015
  76. Tschowri, 2012, Molecular function and potential evolution of the biofilm-modulating blue light-signalling pathway of Escherichia coli, Mol Microbiol, 85, 893, 10.1111/j.1365-2958.2012.08147.x · doi:10.1111/j.1365-2958.2012.08147.x
  77. Murdoch, 2012, Bactericidal effects of 405nm light exposure demonstrated by inactivation of Escherichia, Salmonella, Shigella, Listeria, and Mycobacterium species in liquid suspensions and on exposed surfaces, Sci World J 2012, 137805
  78. Fukui, 2008, Specific-wavelength visible light irradiation inhibits bacterial growth of Porphyromonas gingivalis, J Periodontal Res, 43, 174, 10.1111/j.1600-0765.2007.01009.x · doi:10.1111/j.1600-0765.2007.01009.x
  79. Maclean, 2009, Inactivation of bacterial pathogens following exposure to light from a 405-nanometer light-emitting diode array, Appl Environ Microbiol, 75, 1932, 10.1128/AEM.01892-08 · DOI · Paper page
  80. Wataha, 2004, Biological effects of blue light from dental curing units, Dent Mater, 20, 150, 10.1016/S0109-5641(03)00086-1 · doi:10.1016/s0109-5641(03)00086-1
  81. Ganz, 2005, Helicobacter pylori in patients can be killed by visible light, Lasers Surg Med, 36, 260, 10.1002/lsm.20161 · DOI
  82. Lembo, 2009, Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: a pilot clinical trial, Lasers Surg Med, 41, 337, 10.1002/lsm.20770 · doi:10.1002/lsm.20770
  83. Tsen, 2007, Inactivation of viruses with a very low power visible femtosecond laser, Virol J, 4, 50, 10.1186/1743-422X-4-50 · doi:10.1186/1743-422x-4-50
  84. Tsen, 2007, Inactivation of viruses by laser-driven coherent excitations via impulsive stimulated Raman scattering process, J Biomed Opt, 12, 064030, 10.1117/1.2821713 · doi:10.1117/1.2821713
  85. Tsen, 2007, Inactivation of viruses with a very low power visible femtosecond laser, J Phys: Condens Matter, 19, 322102, 10.1088/0953-8984/19/32/322102 · doi:10.1088/0953-8984/19/32/322102
  86. Tsen, 2007, Selective inactivation of microorganisms with near-infrared femtosecond laser pulses, J Phys: Condens Matter, 19, 472201, 10.1088/0953-8984/19/47/472201 · doi:10.1088/0953-8984/19/47/472201
  87. Tsen, 2008, Inactivation of viruses with a femtosecond laser via impulsive stimulated Raman scattering, Proc SPIE, 6854, 68540N, 10.1117/12.762324 · doi:10.1117/12.762324
  88. Manevitch, 2010, Direct antifungal effect of femtosecond laser on Trichophyton rubrum onychomycosis, Photochem Photobiol, 86, 476, 10.1111/j.1751-1097.2009.00672.x · doi:10.1111/j.1751-1097.2009.00672.x
  89. Wainwright, 2010, ‘Safe’ photoantimicrobials for skin and soft-tissue infections, Int J Antimicrob Agents, 36, 14, 10.1016/j.ijantimicag.2010.03.002 · doi:10.1016/j.ijantimicag.2010.03.002
  90. Feuerstein, 2004, Phototoxic effect of visible light on Porphyromonas gingivalis and Fusobacterium nucleatum: an in vitro study, Photochem Photobiol, 80, 412, 10.1562/2004-06-13-RA-196.1 · doi:10.1562/2004-06-13-ra-196.1
  91. Wheeland, 2012, Safety and effectiveness of a new blue light device for the self-treatment of mild-to-moderate acne, J Clin Aesthet Dermatol, 5, 25
  92. Wheeland, 2011, Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system, J Drugs Dermatol, 10, 596
  93. de Arruda, 2009, A prospective, randomized, open and comparative study to evaluate the safety and efficacy of blue light treatment versus a topical benzoyl peroxide 5% formulation in patients with acne grade II and III, Anais Brasil Dermatol, 84, 463
  94. Tremblay, 2006, Light-emitting diode 415nm in the treatment of inflammatory acne: an open-label, multicentric, pilot investigation, J Cosmet Laser Ther, 8, 31, 10.1080/14764170600607624 · doi:10.1080/14764170600607624

Cited by

See all 286

Metadata

Authors
Yin, R., Dai, T., Avci, P., Jorge, A. E. S., de Melo, W. C., Vecchio, D., Huang, Y.-Y., Gupta, A., & Hamblin, M. R.
Venue
Current Opinion in Pharmacology
Publisher
Elsevier BV
Published
2013-10
Volume
13
Issue
5
Pages
731-762
ISSN
1471-4892 (ISSN-L)
OpenAlex
W2000919475
Cited by
286
References
191
FWCI
2.20
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond. https://app.cochat.ai/papers/10.1016/j.coph.2013.08.009
The paper
Yin, R., Dai, T., Avci, P., Jorge, A. E. S., de Melo, W. C., Vecchio, D., Huang, Y.-Y., Gupta, A., & Hamblin, M. R. (2013). Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond. Current Opinion in Pharmacology. https://doi.org/10.1016/j.coph.2013.08.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.